Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
20 participants
OBSERVATIONAL
2011-08-31
2013-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
U-LABA/ICS Effects on Exercise Performance, Indacaterol
NCT06067100
Effect of Ciclesonide on Exercise Induced Bronchoconstriction
NCT00525772
Study to Investigate the Effect of Inhaled Tiotropium Bromide on Neurokinin-A Induced Bronchoconstriction in Patients With Mild-to-moderate Asthma
NCT00557700
Concentrations of Salmeterol in Blood and Urine
NCT00914901
Green (Sustainable) VENTOLIN - Pharmacokinetics (PK) Study in Healthy Participants
NCT05791565
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Asthma
With positive asthma test
No interventions assigned to this group
Healthy
With no signs of asthma
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* GINA 1-3 for the asthmatic group
* Use of beta2-agonist for at least 12 months for the asthmatic group
* age 18-45
* males
* informed consent
Exclusion Criteria
* airway infection to weeks prior to the study or during the study
* other chronic diseaes than asthma and allergy
* Use of beta2-agonist 6 days prior to the study
* Allergy to the study medicine
18 Years
45 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bispebjerg Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Vibeke Backer
professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Vibeke Backer, MD
Role: PRINCIPAL_INVESTIGATOR
Bispebjerg Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bispebjerg Hospital
Copenhagen, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Procaterol
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.